Complement C1 Inactivator Proteins
"Complement C1 Inactivator Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits.
| Descriptor ID |
D003174
|
| MeSH Number(s) |
D12.644.861.140 D12.776.124.486.274.920.250 D12.776.872.140
|
| Concept/Terms |
Complement C1 Inactivator Proteins- Complement C1 Inactivator Proteins
- Complement Component 1 Inactivator Proteins
- Complement C1 Inhibitor Proteins
- Complement C1 Inactivating Proteins
- Complement C1 Inhibiting Proteins
|
Below are MeSH descriptors whose meaning is more general than "Complement C1 Inactivator Proteins".
Below are MeSH descriptors whose meaning is more specific than "Complement C1 Inactivator Proteins".
This graph shows the total number of publications written about "Complement C1 Inactivator Proteins" by people in this website by year, and whether "Complement C1 Inactivator Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2015 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Complement C1 Inactivator Proteins" by people in Profiles.
-
Urnoski E, Grillo A, Rosini JM. Use of C1 Inhibitor for Angiotensin-Converting Enzyme (ACE) Inhibitor-Induced Angioedema Decreases Mechanical Ventilation Time. J Emerg Med. 2015 Dec; 49(6):e173-5.
-
Giardino F, Cicardi M, Neri S. Use of subcutaneous-C1 INH for acute therapy and prophylaxis of a child with HAE. Pediatr Allergy Immunol. 2015 May; 26(3):296-297.
-
Maurer M, Parish LC. The dermatology view of hereditary angio-oedema: practical diagnostic and management considerations. J Eur Acad Dermatol Venereol. 2013 Feb; 27(2):133-41.
-
Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012 Feb; 67(2):147-57.
-
Cicardi M, Zanichelli A. Replacement therapy with C1 esterase inhibitors for hereditary angioedema. Drugs Today (Barc). 2010 Nov; 46(11):867-74.
-
Breitbart SI, Bielory L. Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool. Allergy Asthma Proc. 2010 Sep-Oct; 31(5):428-34.
-
Nagy N, Grattan CE, McGrath JA. New insights into hereditary angio-oedema: Molecular diagnosis and therapy. Australas J Dermatol. 2010 Aug; 51(3):157-62.
-
Cicardi M, Testoni P, Bergamaschini L, Guzzoni S, Cugno M, Buizza M, Bagnolo F. Antiproteasic activity of C1 inhibitor. Therapeutic perspectives. Ann Ital Med Int. 1994 Jul-Sep; 9(3):180-2.
-
Levy NJ, Ramesh N, Cicardi M, Harrison RA, Davis AE. Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc Natl Acad Sci U S A. 1990 Jan; 87(1):265-8.
-
Ariga T, Igarashi T, Ramesh N, Parad R, Cicardi M, Davis AE. Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon. J Clin Invest. 1989 Jun; 83(6):1888-93.